Dr Bryan Betty: General Practice NZ chair on the impact of weight-loss drugs
Matt Heath & Tyler Adams Afternoons · Newstalk ZB
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Semaglutide drug Wegovy has been available in New Zealand for a couple of months now, and more Kiwis are learning about the effects.
The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer’s, addiction and depression.
General Practice NZ chair Dr Bryan Betty joined the Afternoons team to discuss further - and highlight some potential drawbacks.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.